eLife
Research positions FOXP2 as a bona fide #oncogene driving #ProstateCancer development. https://elifesciences.org/articles/81258?utm_source=mastodon&utm_medium=social&utm_campaign=organic
FOXP2 confers oncogenic effects in prostate cancer

FOXP2, encoding a forkhead-box transcription factor regarded as vital to proper development of human speech, was revealed to have an oncogenic potential and activate MET signaling in prostate cancer.

eLife
Dec 24, 2023 at 11:13amWeb